Price
Target price
€31.80
€31.80
-1.850%
-
-1.850%
€38.99
17.05.24 / Tradegate
WKN: A1W2RM / Symbol: AGIO / Name: Agios / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Agios Pharmaceuticals Inc. Stock
We can see a decrease in the price for Agios Pharmaceuticals Inc.. Compared to yesterday it has lost €0.000 (-1.850%).
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Agios Pharmaceuticals Inc..
As a result the target price of 38 € shows a slightly positive potential of 19.5% compared to the current price of 31.8 € for Agios Pharmaceuticals Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Agios Pharmaceuticals Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Agios Pharmaceuticals Inc. in the next few years
Pros
?
B****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Agios Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc. | -1.850% | 2.581% | 16.058% | 32.500% | 54.369% | -30.461% | -29.693% |
| Ironwood Pharmaceuticals | -2.520% | -7.200% | -17.730% | -37.297% | -43.137% | -40.206% | - |
| Sage Therapeutics Inc. | 3.160% | -0.090% | -6.322% | -77.190% | -44.800% | -81.955% | - |
| Novocure Ltd | -0.830% | 32.158% | 79.353% | -72.036% | 41.786% | -85.944% | - |
Comments
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target lowered by analysts at Royal Bank of Canada from $43.00 to $42.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Show more
Ratings data for AGIO provided by MarketBeat